Moreover, Notch target genes like Hes-1 and Hey-1 were confirmed as prognostic biomarkers in pancreatic cancer; high expression of these genes was associated with shorter overall survival time and progression-free survival time [28, 29]. This evidence concerns the gene HES1 and familial pancreatic carcinoma.